Nippon Life Global Investors Americas, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Nippon Life Global Investors Americas, Inc.
- $2.22 Billion
- Q2 2024
A detailed history of Nippon Life Global Investors Americas, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nippon Life Global Investors Americas, Inc. holds 840 shares of REGN stock, worth $875,397. This represents 0.04% of its overall portfolio holdings.
Number of Shares
840
Previous 1,070
21.5%
Holding current value
$875,397
Previous $1.03 Million
14.29%
% of portfolio
0.04%
Previous 0.05%
Shares
22 transactions
Others Institutions Holding REGN
# of Institutions
1,463Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.37 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.63 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.05 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.83 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $112B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...